Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The AMNIO-BRAIN Trial: A Randomized Trial of Amnioinfusion for Chorioamnionitis Targeting Neonatal Brain Injury Biomarkers

NCT07610642 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT07610642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07610642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The AMNIO-BRAIN Trial: A Randomized Trial of Amnioinfusion for Chorioamnionitis Targeting Neonatal Brain Injury Biomarkers
Lead sponsor
Medical College of Wisconsin
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
December 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amnioinfusion, chorioamnionitis affecting fetus or newborn, neonatal brain injury